"I am sponsor of H.R. 1483, which I hope this committee will give some strong consideration to."
"Sometime the playing field gets slanted against United States manufacturers because of our inability to inspect foreign manufacturers and suppliers of different kinds, isn't that so?"
"Now, one obstacle for ensuring comparable inspections of domestic and foreign facilities is a lack of complete and accurate information that FDA has on generic drug manufacturing establishments."
"Mr. Chairman, I ask unanimous consent that the record will include an analysis of H.R. 1483, the Drug Safety Enforcement Act of 2011, of which I am a sponsor."
"It would be nice if you had more assistance in this, however, from FDA, would it not?"
"I want to thank you for your leadership in this area for many years."
"We are needing and demanding the FDA to govern a global industry."
"I happen to believe that the Food, Drug, and Cosmetic Act should and needs to be updated to reflect the global nature of our drug supply."
"I appreciate your willingness and patience to answer questions."
"We expressed our concern for sensible measures to reduce emissions of hazardous air pollutants in order to protect human health and the environment."
"Would you submit for the record how that would be done, please?"
"I thank you for that. I would also like to see sufficient attention given to that..."